2013 Program

Sun, 11/03

6:00 PM – 8:00 PM

Mon, 11/04

7:00 AM – 7:00 PM
8:00 AM – 9:00 AM
Plenary: Big Science in the 21st Century
  • Margaret Anderson
    Executive Director, FasterCures

  • Francis Collins
    Director, National Institutes of Health
  • Michel Goldman
    Executive Director, Innovative Medicines Initiative
  • Arati Prabhakar
    Director, Defense Advanced Research Projects Agency
  • Marc Tessier-Lavigne
    President, The Rockefeller University
  • Robert Urban
    Head, Boston Innovation Center, Johnson & Johnson
9:15 AM – 10:10 AM
Panel: Philanthropy: Investing for Impact In the Search for Cures
  • Melissa Stevens
    Deputy Executive Director, FasterCures

  • Nancy Brown
    CEO, American Heart Association
  • Ronald G. Harrington
    Chairman, The Harrington Family Foundation; Chairman, BioMotiv
  • Bob More
    Head of Venture Investing, Bill & Melinda Gates Foundation
  • George A. Weiss
    Founder, Orphan Disease Pathway Project
Panel: The Art and Science of Multi-Stakeholder Collaboration
  • Beth Meagher
    Director, Strategy & Operations, Deloitte Consulting LLP

  • Walter Capone
    Chief Operating Officer, Multiple Myeloma Research Foundation
  • Maria Freire
    President, Foundation for the NIH
  • James C. Greenwood
    President & CEO, Biotechnology Industry Organization
  • Gigi Hirsch
    Executive Director, Center for Biomedical Innovation, MIT
  • Michael Rosenblatt
    Executive Vice President and Chief Medical Officer, Merck
Panel: The Other Translation Gap: Turning Outputs into Outcomes
  • Cecilia Arradaza
    Director, Communications & Policy, FasterCures

  • Ben Heywood
    Co-Founder and President, PatientsLikeMe
  • Peter Margolis
    Professor of Pediatrics and Director of Research, James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center
  • Joe V. Selby
    Executive Director, Patient-Centered Outcomes Research Institute
  • Mark Wagar
    President, Heritage Medical Systems
  • John Walsh
    President and CEO, Alpha-1 Foundation
9:15 AM – 12:00 PM
12:00 PM – 1:30 PM
Plenary: Investing in Bioscience: Linking Financial, Human, and Social Returns
  • Michael Milken
    Chairman, Milken Institute; Founder, FasterCures

  • Christopher Egerton-Warburton
    Partner, Lion's Head Global Partners
  • Robert Hugin
    CEO and Chairman, Celgene
  • Rajiv Kaul
    Portfolio Manager, Select Biotechnology Portfolio and Advisor Biotechnology Fund, Fidelity Investments
  • Richard Pops
    Chairman and CEO, Alkermes
1:45 PM – 6:00 PM
3:45 PM – 4:40 PM
Panel: FDA: Recalibrating the Benefit-Risk Equation
  • Kate Rawson
    Senior Editor, RPM Report

  • Robert Conley
    Regulatory Leader, Biomedicines; Distinguished Lilly Scholar, Neurosciences, Eli Lilly and Company
  • Geoff Duyk
    Partner and Managing Director, TPG Biotech
  • Patrick Frey
    Director, Office of Program and Strategic Analysis, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
  • Hugh Hempel
    Co-Founder, Solution Therapeutics; Director and Patient Advocate, The Addi and Cassi Fund
  • Howard McLeod
    Medical Director, Personalized Medicine Institute, Senior Member, Division of Population Sciences, Moffitt Cancer Center
Panel: Learning To Love Failure
  • Luke Timmerman
    Vice President, Life Sciences Initiatives, Xconomy

  • Robi Blumenstein
    President, CHDI Management
  • William Chin
    Executive Vice President, Science and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America
  • George Fisher
    Professor of Medicine (Oncology), Stanford University School of Medicine
  • Stephen Friend
    President, Sage Bionetworks
  • Story Landis
    Director, National Institute for Neurological Disorders and Stroke, NIH
Panel: Reducing Drag: New Approaches to IP Negotiation and Technology Licensing
  • Robert Cook-Deegan
    Institute for Genome Sciences & Policy and Sanford School of Public Policy, Duke University; FasterCures Fellow

  • David Clifford
    Founder, Avicenna LLC
  • Steven M. Ferguson
    Deputy Director, Licensing and Entrepreneurship, Office of Technology Transfer, National Institutes of Health
  • Justin McCarthy
    Senior Vice President & General Counsel, Worldwide Research & Development, Pfizer
  • Lita Nelsen
    Director, Technology Licensing Office, Massachusetts Institute of Technology
  • Josh Sommer
    Executive Director, Chordoma Foundation
4:45 PM – 6:00 PM
9:00 PM – 10:00 PM

Tue, 11/05

7:00 AM – 1:00 PM
8:00 AM – 9:00 AM
Plenary: Five People Changing the Face of Bioscience
  • Josh Sommer
    Executive Director, Chordoma Foundation

  • Laura Deming
    Partner, The Longevity Fund
  • Geoffrey Ling
    Deputy Director, Defense Sciences Office, Defense Advanced Research Projects Agency
  • Jessica Richman
    Co-Founder and CEO, uBiome
  • Halle Tecco
    Co-Founder and CEO, Rock Health
  • Adrien Treuille
    Assistant Professor, Computer Science and Robotics, Carnegie Mellon University
9:15 AM – 10:10 AM
Panel: Mental Health: Research and Development at a Crossroads
  • Kathi E. Hanna
    Senior Fellow, FasterCures

  • Thomas R. Insel
    Director, National Institute of Mental Health, NIH
  • Jay Lombard
    Chief Scientific Officer and Medical Director, Genomind
  • Jeffrey Nye
    Vice President Neuroscience Innovation and Scientific Partnership Strategy, Janssen Research and Development, LLC
  • Robert Ring
    Chief Science Officer, Autism Speaks
  • Paul Weiss
    Director, California NanoSystems Institute
Panel: Rare Diseases: Hot, but for How Long?
  • Matthew Herper
    Senior Editor, Forbes Magazine

  • Mike Collins
    Vice President for Global Clinical Operations, Alexion Pharmaceuticals
  • Sharon Hesterlee
    Vice President for Research, Parent Project Muscular Dystrophy
  • Matthew Perry
    Portfolio Manager, BVF Partners L.P.
  • J. Russell Teagarden
    Senior Vice President, Medical & Scientific Affairs, National Organization for Rare Disorders
  • Eugene Williams
    CEO, DART Therapeutics
Panel: The New Value Proposition for Academic Science
  • Roxanne Khamsi
    Chief News Editor, Nature Medicine

  • Christopher Austin
    Director, National Center for Advancing Translational Sciences
  • Louis J. DeGennaro
    Executive Vice President and Chief Mission Officer, Leukemia and Lymphoma Society
  • Conor Evans
    Assistant Professor, Harvard Medical School
  • Pearl Huang
    Vice President, Global Head of Discovery Partnerships in Academia, Alternative Discovery and Development, GlaxoSmithKline
  • Jack Tillman
    Executive Director, Emory Innovations, Emory University
9:15 AM – 12:40 PM
11:45 AM – 12:40 PM
Panel: Beyond Venture Capital
  • Gregory C. Simon

  • Ilan Ganot
    Founder and CEO, Solid Ventures
  • Andrew W. Lo
    Charles E. and Susan T. Harris Professor, Professor of Finance; Director, Laboratory for Financial Engineering, Massachusetts Institute of Technology
  • Paul M. Meister
    Chairman and CEO, inVentiv Health
  • Jeffrey Rowbottom
    Managing Director, Kohlberg Kravis Roberts & Co.
  • Erika Smith
    Venture Advisor, Rock Spring Ventures; Deputy Director, Yale Entrepreneurial Institute (YEI) and YEI Innovation Fund, Yale University
Panel: Reimbursement: Can Value Drive Innovation?
  • Dean Rosen
    Partner, Mehlman Vogel Castagnetti Inc.

  • Robert J. Beall
    President and CEO, Cystic Fibrosis Foundation
  • Jo Carol Hiatt
    Chair, National Product Council, Kaiser Permanente
  • Shari Ling
    Deputy Chief Medical Officer, Centers for Medicare & Medicaid Services
  • Alan Russell
    Highmark Distinguished Career Professor, Carnegie Mellon University, and Chief Innovation Officer and Executive Vice President, Allegheny Health Network
  • Stephen J. Ubl
    President and CEO, AdvaMed
Panel: The People Behind the Science: Will Work for Food
  • Adam Ruben
    Scientist, Sanaria Inc.; Columnist, Science Careers

  • Otis Brawley
    Chief Medical Officer, American Cancer Society
  • Jonathan Dordick
    Vice President for Research and Howard P. Isermann Professor of Chemical and Biological Engineering, Rensselaer Polytechnic Institute
  • Sally Rockey
    Deputy Director for Extramural Research, National Institutes of Health
  • Cindy Wu
    Co-Founder, Microryza
1:00 PM – 2:30 PM
Plenary: Big Data Needs Big Ideas
  • Lesa Mitchell
    Vice President, Innovation and Networks, Ewing Marion Kauffman Foundation

  • Thomas Frieden
    Director, U.S. Centers for Disease Control and Prevention
  • Jeff Hammerbacher
    Assistant Professor, Genetics and Genomic Sciences, Mount Sinai Medical Center; Co-Founder and Chief Scientist, Cloudera
  • Gary J. Nabel
    Senior Vice President & Chief Scientific Officer, Sanofi
  • Andy Palmer
    Founder, Koa Labs
  • Roni Zeiger
    Co-Founder and CEO, Smart Patients
2:45 PM – 4:40 PM
2:45 PM – 3:45 PM
Time Equals Lives Talks
  • Nancy Brinker
    Founder, Susan G. Komen Foundation
  • Meryl Comer
    President, Geoffrey Beene Foundation Alzheimer's Initiative; Founder, WomenAgainstAlzheimers
  • Kafui Dzirasa
    Department of Psychiatry and Behavioral Sciences, Center for Neuroengineering, Duke University Medical Center
  • Geoffrey Ling
    Deputy Director, Defense Sciences Office, Defense Advanced Research Projects Agency
  • Shari Ling
    Deputy Chief Medical Officer, Centers for Medicare & Medicaid Services
  • Susan Love
    Chief Visionary Officer, Dr. Susan Love Research Foundation